PortfoliosLab logo
Daxor Corporation (DXR)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US2394671034

CUSIP

239467103

IPO Date

Mar 17, 1992

Highlights

Market Cap

$40.11M

EPS (TTM)

-$0.09

Total Revenue (TTM)

$767.06K

Gross Profit (TTM)

$692.42K

EBITDA (TTM)

-$962.48K

Year Range

$6.55 - $10.00

Target Price

$23.50

Short %

0.34%

Short Ratio

1.54

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Daxor Corporation

Performance

Performance Chart


Loading data...

S&P 500

Returns By Period

Daxor Corporation (DXR) returned 5.77% year-to-date (YTD) and -11.83% over the past 12 months. Over the past 10 years, DXR returned 1.59% annually, underperforming the S&P 500 benchmark at 10.84%.


DXR

YTD

5.77%

1M

9.12%

6M

-13.93%

1Y

-11.83%

3Y*

-13.53%

5Y*

-9.40%

10Y*

1.59%

^GSPC (Benchmark)

YTD

0.52%

1M

6.32%

6M

-1.44%

1Y

12.25%

3Y*

12.45%

5Y*

14.20%

10Y*

10.84%

*Annualized

Monthly Returns

The table below presents the monthly returns of DXR, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-0.07%-1.63%7.41%-9.14%10.25%5.77%
2024-9.48%-9.21%12.68%8.89%-9.50%6.39%-5.20%-4.36%2.37%0.12%10.97%-19.98%-19.90%
2023-6.12%-3.49%32.53%4.00%-16.08%-0.00%2.67%-1.99%-2.90%-14.82%-1.88%22.45%4.80%
2022-6.69%1.14%-0.00%7.75%10.06%4.51%5.76%-1.58%-3.57%-12.68%-17.81%-3.68%-18.83%
20218.00%-11.89%1.73%-19.67%-3.81%13.37%-14.29%5.64%21.70%-7.45%1.76%2.59%-9.72%
2020-1.49%-7.12%56.86%17.37%-15.84%10.09%17.59%-6.38%-2.48%-7.62%-11.34%-3.10%32.98%
201978.78%31.41%-41.55%-15.72%-12.22%-4.56%14.97%-1.75%7.13%-3.69%1.46%0.00%14.63%
2018-2.61%-18.59%166.11%-27.92%4.42%-7.63%-20.42%-6.42%0.81%32.40%-4.23%29.34%80.59%
2017-2.09%10.28%-16.85%-3.11%-5.16%-8.82%-4.03%-11.43%-3.03%-18.98%21.98%-8.87%-44.17%
20160.66%5.23%-0.32%0.45%-0.74%1.25%-0.25%-0.99%-1.63%3.18%4.68%-2.69%8.84%
2015-12.32%10.62%-15.95%34.63%-5.35%-5.52%-6.57%-4.37%41.34%1.96%-4.76%-9.06%9.44%
20140.42%3.29%16.57%0.62%-7.11%-10.62%1.74%-0.85%-11.06%4.52%-2.63%11.29%2.64%
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of DXR is 33, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of DXR is 3333
Overall Rank
The Sharpe Ratio Rank of DXR is 3737
Sharpe Ratio Rank
The Sortino Ratio Rank of DXR is 3333
Sortino Ratio Rank
The Omega Ratio Rank of DXR is 3333
Omega Ratio Rank
The Calmar Ratio Rank of DXR is 3737
Calmar Ratio Rank
The Martin Ratio Rank of DXR is 2727
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Daxor Corporation (DXR) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Daxor Corporation Sharpe ratios as of May 30, 2025 (values are recalculated daily):

  • 1-Year: -0.23
  • 5-Year: -0.17
  • 10-Year: 0.02
  • All Time: 0.09

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Daxor Corporation compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

Dividend History

Daxor Corporation provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%0.10%0.20%0.30%0.40%0.50%0.60%0.70%$0.00$0.01$0.02$0.03$0.0420142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.03$0.03$0.03$0.04$0.03

Dividend yield

0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.37%0.66%0.36%0.53%0.43%

Monthly Dividends

The table displays the monthly dividend distributions for Daxor Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00$0.00$0.00$0.00$0.00
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2020$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2018$0.03$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.03
2017$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.03$0.03
2016$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.03$0.03
2015$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.04$0.04
2014$0.03$0.03

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Daxor Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Daxor Corporation was 82.52%, occurring on Mar 2, 2018. Recovery took 593 trading sessions.

The current Daxor Corporation drawdown is 65.80%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-82.52%Mar 14, 20003948Mar 2, 2018593Jul 17, 20204541
-70.35%Jul 20, 20201130Feb 12, 2025
-62.83%Jul 31, 1992215Jun 8, 1993721Jul 1, 1996936
-48.68%Nov 20, 199699Apr 30, 1997183Feb 2, 1998282
-31.93%Jul 5, 199625Aug 15, 199650Oct 28, 199675
Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Daxor Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Daxor Corporation, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 1,050.0% positive surprise.


-1.00-0.500.000.501.001.50AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober
1.54
0
Actual
Estimate

Valuation

The Valuation section provides an overview of how Daxor Corporation is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for DXR compared to other companies in the Medical Instruments & Supplies industry. DXR currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for DXR relative to other companies in the Medical Instruments & Supplies industry. Currently, DXR has a P/S ratio of 335.1. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for DXR in comparison with other companies in the Medical Instruments & Supplies industry. Currently, DXR has a P/B value of 1.1. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items